Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, destructiveHint=false. The description adds substantial behavioral context beyond those flags: it discloses that LEI/FIGI enrichment degrades gracefully when GLEIF/OpenFIGI are down, that ambiguous name matches return figi_candidates instead of asserting a single answer, that unresolved identifiers are stated explicitly under `unresolved`, and that internal cascading means calling this tool replaces 2-3 manual lookups. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense and front-loaded with examples and the primary use case, so an agent can quickly grasp the tool. However, it runs long, embedding edge-case details (e.g., non-equity instruments, ISIN examples) that, while valuable, could be trimmed or moved into separate guidance. Every sentence earns its place, but the length slightly dilutes the read.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a 2-parameter tool with no output schema, the description is complete: it covers input formats, resolution behavior, failure/degradation behavior, and even a citation format for drug lookups. It does not enumerate the full return shape, but the detailed discussion of fields such as `figi_candidates`, `unresolved`, and source labels gives strong context. The only gap is that it doesn't explicitly say what a fully resolved response object looks like beyond those fragments.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description exceeds that baseline by giving detailed semantic guidance for the `value` parameter: for company it accepts ticker/CIK/ISIN/name, and for drug brand/generic. It also warns against including trailing security-class words for bond lookups and clarifies that an ISIN resolves to the legal entity that issued the security. This adds meaning beyond the schema's terse descriptions, though the `type` enum is itself straightforward.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language examples ("What's the ticker for…", "find the CIK for…") followed by the core verb phrase "resolve a user-spoken NAME to the canonical/official identifiers other tools require as input." This gives a specific action on a specific resource, distinguishes it from siblings like entity_profile (identity resolution vs. profiling), and explains why the agent would reach for it first ("Use FIRST whenever you have a name but need an ID").

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides an explicit when-to-use directive: "Use FIRST whenever you have a name but need an ID." It also details which input formats are accepted (ticker, CIK, ISIN, company name, drug brand/generic) and, crucially, what to avoid ("never the question's full noun phrase"). It even explains fallback behavior across the two supported types, giving the agent clear routing context versus sibling tools that perform research, comparisons, or profiles.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation3/5

Tools like ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are very similar, causing potential confusion. The open_payments_* tools are clearly differentiated, but the mix of generic Pipeworx tools with domain-specific ones creates overlapping purposes.

Naming Consistency2/5

Tool names mix conventions: some use snake_case (ask_pipeworx, open_payments_company), while others use less consistent patterns (deep_research, generate_llms_txt). The open_payments_* tools have a consistent prefix, but the overall set lacks a unified naming scheme.

Tool Count2/5

With 41 tools, the server is heavily overloaded for a domain focused on CMS Open Payments. The majority of tools are general-purpose Pipeworx tools unrelated to the server's name, making the count feel excessive and unfocused.

Completeness3/5

The open_payments_* tools cover the CMS Open Payments domain well (search, company, physician, history, etc.). However, the inclusion of many unrelated Pipeworx tools means the server as a whole is not cohesive, and the completeness of the named domain is overshadowed.